CN Stock MarketDetailed Quotes

301277 Newland Pharmaceutical

Watchlist
  • 13.65
  • -0.25-1.80%
Market Closed Jun 20 15:00 CST
3.82BMarket Cap22.71P/E (TTM)

Newland Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
25.69%240.53M
428.07%270.02M
626.83%259.7M
674.96%229.71M
--191.38M
49.46%51.13M
--35.73M
-24.63%29.64M
----
-5.84%34.21M
Transactional financial assets
6.74%620.07M
-15.95%589.5M
10,488.60%530.4M
9,141.65%561.23M
--580.93M
7,993.06%701.36M
--5.01M
-36.32%6.07M
----
--8.67M
Notes receivable and accounts receivable
-21.71%241.07M
-33.25%177.99M
8.00%230.01M
-15.36%251.51M
--307.91M
17.31%266.65M
--212.98M
36.65%297.15M
----
75.48%227.32M
-Notes receivable
-38.30%120.53M
-21.16%68.99M
68.03%106.45M
71.37%133.89M
--195.36M
14.84%87.51M
--63.35M
-22.62%78.13M
----
122.49%76.2M
-Accounts receivable
7.10%120.54M
-39.16%109M
-17.42%123.56M
-46.29%117.63M
--112.55M
18.55%179.15M
--149.63M
88.01%219.02M
----
58.58%151.12M
Other receivables (including interest and dividends)
-57.41%195.22K
-26.30%189.67K
81.47%253.44K
238.35%289.58K
--458.35K
61.38%257.36K
--139.65K
-75.29%85.58K
----
-62.19%159.48K
-Other receivable
----
----
----
238.35%289.58K
----
61.38%257.36K
--139.65K
-75.29%85.58K
----
-62.19%159.48K
Advance payment
187.65%8.96M
732.44%19.65M
158.46%8.81M
67.39%3.74M
--3.12M
81.73%2.36M
--3.41M
41.00%2.23M
----
-11.89%1.3M
Inventories
-1.57%34.44M
-42.07%31M
-56.60%27.48M
-46.52%23.01M
--34.99M
-31.88%53.52M
--63.33M
-34.29%43.03M
----
59.00%78.57M
Receivable financing
-23.62%91.04M
-32.93%62.91M
-14.36%136.37M
18.36%104.33M
--119.19M
121.85%93.8M
--159.23M
77.47%88.15M
----
-15.01%42.28M
Other current assets
-52.52%6.48M
-70.07%5.39M
-66.97%4.82M
-87.81%1.34M
--13.65M
112.08%18.02M
--14.61M
283.83%10.99M
----
445.50%8.5M
Total current assets
-0.71%1.24B
-2.57%1.16B
142.26%1.2B
146.19%1.18B
--1.25B
196.03%1.19B
--494.44M
23.58%477.35M
----
49.35%401M
Non Current assets
Fixed assets
----
----
----
25.15%250.29M
----
21.77%234.58M
--199.64M
4.45%199.99M
----
8.24%192.65M
Constru in process
----
----
----
182.47%74.32M
----
67.64%55.35M
--32.62M
-1.45%26.31M
----
1.52%33.02M
Intangible assets
-1.88%37.77M
-1.78%38.08M
-1.42%38.44M
-2.13%38.43M
--38.49M
-2.35%38.77M
--38.99M
-2.41%39.27M
----
-0.49%39.71M
Long deferred expense
331.38%5.06M
334.03%5.61M
327.03%6.04M
--6.58M
--1.17M
--1.29M
--1.41M
----
----
----
Deferred tax assets
----
----
----
----
----
----
----
-78.01%162.85K
----
22.09%1.01M
Usufruct assets
-45.77%2.68M
-46.06%3.01M
-25.79%3.65M
-12.73%4.75M
--4.93M
--5.59M
--4.91M
--5.44M
----
--0
Other non current assets
15.11%13.69M
89.15%20.96M
-79.77%4.52M
-30.15%9.5M
--11.9M
2,074.13%11.08M
--22.33M
1,669.44%13.6M
----
-77.18%509.59K
Total non current assets
34.41%482.77M
30.63%452.86M
31.67%394.89M
34.80%383.87M
--359.17M
29.89%346.66M
--299.91M
9.56%284.77M
----
5.30%266.9M
Total assets
7.13%1.73B
4.94%1.61B
100.51%1.59B
104.57%1.56B
113.10%1.61B
129.64%1.53B
--794.35M
17.94%762.12M
--755.88M
27.96%667.9M
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
----
--93.04M
4.76%88.55M
----
1.34%91.33M
Notes payable and accounts payable
-8.55%124.83M
-17.50%87.75M
4.54%107.08M
12.37%112.04M
--136.51M
32.54%106.37M
--102.43M
12.21%99.71M
----
84.50%80.26M
-Notes payable
----
----
----
----
--2.99M
119.46%11.31M
--7.86M
523.60%15.84M
----
--5.15M
-Accounts payable
-6.51%124.83M
-7.69%87.75M
13.23%107.08M
33.59%112.04M
--133.52M
26.58%95.07M
--94.57M
-2.84%83.86M
----
72.66%75.1M
Contract liabilities
-15.79%4.64M
-3.92%4.43M
-26.55%5.6M
-51.91%2.73M
--5.5M
174.46%4.61M
--7.63M
-26.14%5.68M
----
309.86%1.68M
Salaries payable
23.33%14.39M
22.06%17.27M
3.90%14.09M
22.58%12.93M
--11.66M
10.05%14.15M
--13.56M
6.04%10.55M
----
9.58%12.86M
Taxs payable
-68.44%3.14M
56.99%1.42M
65.41%5.65M
-24.29%4.82M
--9.94M
-93.13%903.6K
--3.41M
-29.29%6.36M
----
68.54%13.14M
Other payable (including interest and dividends)
22.49%25.77M
-1.91%26.03M
25.86%17.64M
70.14%23.53M
--21.04M
61.49%26.54M
--14.02M
-68.89%13.83M
----
-31.86%16.43M
-Other payable
----
----
----
70.14%23.53M
----
61.49%26.54M
--14.02M
-68.89%13.83M
----
-31.86%16.43M
Non current liabilities due within one year
-26.90%1.87M
-29.89%1.99M
-80.10%2.51M
-78.05%2.49M
--2.56M
-39.06%2.84M
--12.63M
386.66%11.36M
----
--4.66M
Other current liabilities
-15.79%602.63K
-3.92%575.87K
-78.08%217.31K
-51.91%355.27K
--715.64K
174.46%599.34K
--991.39K
-26.14%738.74K
----
309.86%218.37K
Total current liabilities
-6.76%175.24M
-10.60%139.47M
-38.32%152.79M
-32.89%158.89M
--187.94M
-29.27%156.01M
--247.7M
-4.46%236.77M
----
24.10%220.58M
Current liabilities
Long term loan
----
----
----
----
----
----
--34.66M
-3.19%31.68M
----
51.79%30.39M
Deferred tax liabilities
120.58%9.44M
81.41%9.78M
912.58%2.21M
--2.49M
--4.28M
--5.39M
--218.64K
----
----
----
Long term deferred income
239.79%34.78M
-2.50%10.04M
-2.48%10.11M
-2.47%10.17M
--10.23M
-2.44%10.3M
--10.36M
-2.41%10.43M
----
-2.38%10.56M
Lease liabilities
-77.50%496.43K
-74.75%727.44K
-71.22%687.36K
-54.74%1.33M
--2.21M
--2.88M
--2.39M
--2.94M
----
--0
Total non current liabilities
167.42%44.71M
10.64%20.54M
-72.69%13.01M
-68.94%13.99M
--16.72M
-54.65%18.57M
--47.63M
3.77%45.04M
----
32.79%40.95M
Total liabilities
7.47%219.95M
-8.34%160.02M
-43.86%165.79M
-38.65%172.88M
--204.66M
-33.24%174.58M
--295.33M
-3.23%281.82M
----
25.39%261.53M
Shareholders equity
Paid-in capital
50.00%200.04M
50.00%200.04M
100.04%200.04M
100.04%200.04M
--133.36M
33.36%133.36M
--100M
0.00%100M
----
0.00%100M
Capital reserve funds
-8.42%724.78M
-8.42%724.78M
8,665.88%724.78M
9,773.01%724.78M
--791.46M
14,325.11%791.46M
--8.27M
102.10%7.34M
----
208.59%5.49M
Surplus reserve funds
30.31%86.89M
27.14%80.84M
55.77%77.89M
46.70%73.35M
--66.68M
27.17%63.58M
--50M
0.00%50M
----
0.00%50M
Retained profit
20.08%486.11M
20.78%436.25M
25.66%416.9M
20.51%378.47M
--404.83M
48.96%361.2M
--331.78M
62.22%314.07M
----
53.95%242.48M
Specific reserves
0.81%6.85M
-3.53%6.11M
-7.90%5.11M
27.19%6.76M
--6.79M
38.82%6.33M
--5.55M
42.86%5.32M
----
11.02%4.56M
Shareholders equity without minority interests
7.24%1.5B
6.79%1.45B
187.48%1.42B
190.19%1.38B
220.24%1.4B
236.85%1.36B
--495.59M
35.84%476.73M
--438.15M
28.44%402.53M
Minority interests
-68.80%941.01K
-54.71%1.47M
-35.21%2.22M
-23.34%2.74M
--3.02M
-15.52%3.25M
--3.43M
-10.63%3.57M
----
--3.85M
Total shareholder equity
7.07%1.51B
6.64%1.45B
185.95%1.43B
188.60%1.39B
--1.41B
234.47%1.36B
--499.02M
35.31%480.3M
----
29.67%406.38M
Total liabilityies and equity
7.13%1.73B
4.94%1.61B
100.51%1.59B
104.57%1.56B
113.10%1.61B
129.64%1.53B
--794.35M
17.94%762.12M
--755.88M
27.96%667.9M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 25.69%240.53M428.07%270.02M626.83%259.7M674.96%229.71M--191.38M49.46%51.13M--35.73M-24.63%29.64M-----5.84%34.21M
Transactional financial assets 6.74%620.07M-15.95%589.5M10,488.60%530.4M9,141.65%561.23M--580.93M7,993.06%701.36M--5.01M-36.32%6.07M------8.67M
Notes receivable and accounts receivable -21.71%241.07M-33.25%177.99M8.00%230.01M-15.36%251.51M--307.91M17.31%266.65M--212.98M36.65%297.15M----75.48%227.32M
-Notes receivable -38.30%120.53M-21.16%68.99M68.03%106.45M71.37%133.89M--195.36M14.84%87.51M--63.35M-22.62%78.13M----122.49%76.2M
-Accounts receivable 7.10%120.54M-39.16%109M-17.42%123.56M-46.29%117.63M--112.55M18.55%179.15M--149.63M88.01%219.02M----58.58%151.12M
Other receivables (including interest and dividends) -57.41%195.22K-26.30%189.67K81.47%253.44K238.35%289.58K--458.35K61.38%257.36K--139.65K-75.29%85.58K-----62.19%159.48K
-Other receivable ------------238.35%289.58K----61.38%257.36K--139.65K-75.29%85.58K-----62.19%159.48K
Advance payment 187.65%8.96M732.44%19.65M158.46%8.81M67.39%3.74M--3.12M81.73%2.36M--3.41M41.00%2.23M-----11.89%1.3M
Inventories -1.57%34.44M-42.07%31M-56.60%27.48M-46.52%23.01M--34.99M-31.88%53.52M--63.33M-34.29%43.03M----59.00%78.57M
Receivable financing -23.62%91.04M-32.93%62.91M-14.36%136.37M18.36%104.33M--119.19M121.85%93.8M--159.23M77.47%88.15M-----15.01%42.28M
Other current assets -52.52%6.48M-70.07%5.39M-66.97%4.82M-87.81%1.34M--13.65M112.08%18.02M--14.61M283.83%10.99M----445.50%8.5M
Total current assets -0.71%1.24B-2.57%1.16B142.26%1.2B146.19%1.18B--1.25B196.03%1.19B--494.44M23.58%477.35M----49.35%401M
Non Current assets
Fixed assets ------------25.15%250.29M----21.77%234.58M--199.64M4.45%199.99M----8.24%192.65M
Constru in process ------------182.47%74.32M----67.64%55.35M--32.62M-1.45%26.31M----1.52%33.02M
Intangible assets -1.88%37.77M-1.78%38.08M-1.42%38.44M-2.13%38.43M--38.49M-2.35%38.77M--38.99M-2.41%39.27M-----0.49%39.71M
Long deferred expense 331.38%5.06M334.03%5.61M327.03%6.04M--6.58M--1.17M--1.29M--1.41M------------
Deferred tax assets -----------------------------78.01%162.85K----22.09%1.01M
Usufruct assets -45.77%2.68M-46.06%3.01M-25.79%3.65M-12.73%4.75M--4.93M--5.59M--4.91M--5.44M------0
Other non current assets 15.11%13.69M89.15%20.96M-79.77%4.52M-30.15%9.5M--11.9M2,074.13%11.08M--22.33M1,669.44%13.6M-----77.18%509.59K
Total non current assets 34.41%482.77M30.63%452.86M31.67%394.89M34.80%383.87M--359.17M29.89%346.66M--299.91M9.56%284.77M----5.30%266.9M
Total assets 7.13%1.73B4.94%1.61B100.51%1.59B104.57%1.56B113.10%1.61B129.64%1.53B--794.35M17.94%762.12M--755.88M27.96%667.9M
Liabilities
Current liabilities
Short term loan --------------------------93.04M4.76%88.55M----1.34%91.33M
Notes payable and accounts payable -8.55%124.83M-17.50%87.75M4.54%107.08M12.37%112.04M--136.51M32.54%106.37M--102.43M12.21%99.71M----84.50%80.26M
-Notes payable ------------------2.99M119.46%11.31M--7.86M523.60%15.84M------5.15M
-Accounts payable -6.51%124.83M-7.69%87.75M13.23%107.08M33.59%112.04M--133.52M26.58%95.07M--94.57M-2.84%83.86M----72.66%75.1M
Contract liabilities -15.79%4.64M-3.92%4.43M-26.55%5.6M-51.91%2.73M--5.5M174.46%4.61M--7.63M-26.14%5.68M----309.86%1.68M
Salaries payable 23.33%14.39M22.06%17.27M3.90%14.09M22.58%12.93M--11.66M10.05%14.15M--13.56M6.04%10.55M----9.58%12.86M
Taxs payable -68.44%3.14M56.99%1.42M65.41%5.65M-24.29%4.82M--9.94M-93.13%903.6K--3.41M-29.29%6.36M----68.54%13.14M
Other payable (including interest and dividends) 22.49%25.77M-1.91%26.03M25.86%17.64M70.14%23.53M--21.04M61.49%26.54M--14.02M-68.89%13.83M-----31.86%16.43M
-Other payable ------------70.14%23.53M----61.49%26.54M--14.02M-68.89%13.83M-----31.86%16.43M
Non current liabilities due within one year -26.90%1.87M-29.89%1.99M-80.10%2.51M-78.05%2.49M--2.56M-39.06%2.84M--12.63M386.66%11.36M------4.66M
Other current liabilities -15.79%602.63K-3.92%575.87K-78.08%217.31K-51.91%355.27K--715.64K174.46%599.34K--991.39K-26.14%738.74K----309.86%218.37K
Total current liabilities -6.76%175.24M-10.60%139.47M-38.32%152.79M-32.89%158.89M--187.94M-29.27%156.01M--247.7M-4.46%236.77M----24.10%220.58M
Current liabilities
Long term loan --------------------------34.66M-3.19%31.68M----51.79%30.39M
Deferred tax liabilities 120.58%9.44M81.41%9.78M912.58%2.21M--2.49M--4.28M--5.39M--218.64K------------
Long term deferred income 239.79%34.78M-2.50%10.04M-2.48%10.11M-2.47%10.17M--10.23M-2.44%10.3M--10.36M-2.41%10.43M-----2.38%10.56M
Lease liabilities -77.50%496.43K-74.75%727.44K-71.22%687.36K-54.74%1.33M--2.21M--2.88M--2.39M--2.94M------0
Total non current liabilities 167.42%44.71M10.64%20.54M-72.69%13.01M-68.94%13.99M--16.72M-54.65%18.57M--47.63M3.77%45.04M----32.79%40.95M
Total liabilities 7.47%219.95M-8.34%160.02M-43.86%165.79M-38.65%172.88M--204.66M-33.24%174.58M--295.33M-3.23%281.82M----25.39%261.53M
Shareholders equity
Paid-in capital 50.00%200.04M50.00%200.04M100.04%200.04M100.04%200.04M--133.36M33.36%133.36M--100M0.00%100M----0.00%100M
Capital reserve funds -8.42%724.78M-8.42%724.78M8,665.88%724.78M9,773.01%724.78M--791.46M14,325.11%791.46M--8.27M102.10%7.34M----208.59%5.49M
Surplus reserve funds 30.31%86.89M27.14%80.84M55.77%77.89M46.70%73.35M--66.68M27.17%63.58M--50M0.00%50M----0.00%50M
Retained profit 20.08%486.11M20.78%436.25M25.66%416.9M20.51%378.47M--404.83M48.96%361.2M--331.78M62.22%314.07M----53.95%242.48M
Specific reserves 0.81%6.85M-3.53%6.11M-7.90%5.11M27.19%6.76M--6.79M38.82%6.33M--5.55M42.86%5.32M----11.02%4.56M
Shareholders equity without minority interests 7.24%1.5B6.79%1.45B187.48%1.42B190.19%1.38B220.24%1.4B236.85%1.36B--495.59M35.84%476.73M--438.15M28.44%402.53M
Minority interests -68.80%941.01K-54.71%1.47M-35.21%2.22M-23.34%2.74M--3.02M-15.52%3.25M--3.43M-10.63%3.57M------3.85M
Total shareholder equity 7.07%1.51B6.64%1.45B185.95%1.43B188.60%1.39B--1.41B234.47%1.36B--499.02M35.31%480.3M----29.67%406.38M
Total liabilityies and equity 7.13%1.73B4.94%1.61B100.51%1.59B104.57%1.56B113.10%1.61B129.64%1.53B--794.35M17.94%762.12M--755.88M27.96%667.9M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg